• (PLX AI) – Pharma Mar FY net income EUR 93 million vs. estimate EUR 59 million.
  • • FY revenue EUR 230 million vs. estimate EUR 210 million
  • • FY EBITDA EUR 97.8 million vs. estimate EUR 76 million
  • • Dividend EUR 0.65 per share
  • • The Group is cash generative and closed 2021 with a cash and cash equivalents position of EUR 212 million

Quelle: PLX AI